12,000-Patient study tests new cholesterol pill in real life
NCT ID NCT07515560
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow 12,000 Korean adults with dyslipidemia (high cholesterol) who are prescribed Baroezet Tablet by their doctor. Researchers will measure changes in LDL ("bad") cholesterol and other fats in the blood over 24 weeks, and track any side effects. The goal is to see how well the medication works in everyday medical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Multiple centers in Republic of Korea
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hormone therapy may shield menopausal hearts and brains — a trial puts it to the test
- Could vitamin d levels influence cholesterol in obese diabetes patients?
- Could a tropical oil and green exercise boost fat burning and calm your mind?
- Sugarcane supplement and exercise may team up to tame cholesterol
- Could a common cholesterol drug boost mood treatment?
- Could vinegar and fasting fix prediabetes cholesterol?